🇺🇸 FDA
Patent

US 8080241

Viruses for the treatment of cellular proliferative disorders

granted A61KA61K35/13A61K35/76

Quick answer

US patent 8080241 (Viruses for the treatment of cellular proliferative disorders) held by ONCOLYTICS BIOTECH INC. expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ONCOLYTICS BIOTECH INC.
Grant date
Tue Dec 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
48
CPC classes
A61K, A61K35/13, A61K35/76, A61K35/761, A61K38/13